Objective: The objective of the study was to evaluate and optimize compression process variables of Esomeprazole (Multiunit particulate system) MUPS tablet. Materials and methods: A three-factor, two-level, full factorial design was used to investigate the influence process variables Viz. Main compression force, Pre-compression force and Turret speed. Responses studied were Weight variation, Hardness, Thickness, Friability, Content uniformity, Drug release in 0.1N HCl at 120min and drug release in pH 6.5 simulated intestinal fluid at 15 min. Results and discussion: Main compression force and the Pre-compression force had a significant influence on hardness, thickness, drug release in 0.1N HCl at 120min and drug release in pH 6.5 SIF at 15min. Higher compression force leads to breakage of pellets during compression which showed impact drug release at acid stage. Turret speed had significant impact on final weight variation and content uniformity. The optimized process parameters Main compression force: 11.33 kP, Pre-compression force: 2.72 Kp and Turret speed: 23.56 rpm showed desired physical characteristics and drug release in 0.1N HCl which will result in lesser degradation of API at acid stage. Conclusion: It is concluded that Compression process variables in preparation of Esomeprazole MUPS were successfully evaluated using Design of Experiment approach.
INTRODUCTION
Solid oral controlled and modified release drug delivery systems are the most acceptable and reliable dosage form to patients. Multi-particulate systems (MUPS) are mainly oral dosage forms consisting of a multiplicity of small discrete units, each exhibiting some desired characteristics. In these systems, the dosage of the drug substances is divided on a plurality of subunit, typically consisting of thousands of spherical particles 1 . MUPS offer various advantages over other systems, including reduced risk of local irritation and toxicity, predictable bioavailability, reduced likelihood of dose dumping, minimized fluctuations in plasma concentration of drug, and high dose-strength administration 2 .
Compression of pellets is a major challenge which involves segregation of pellets in hopper as well as on turret. Turret speed may lead to segregation of pellets which may have impact on final DP-CQA's Assay, drug release and content uniformity of tablets 3, 4 . Other factors that may have impact on DP-CQAs are size, shape and density of pellets, nature of polymer and polymer coating, amount of polymer coating and nature and amount of extra-granular excipients
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Esomeprazole Magnesium selected as model drug for study, which belongs to Proton pump inhibitors class. Proton pump inhibitors are potent inhibitors of acid secretion. These compounds are susceptible to degradation in acid media. Therefore, formulation was prepared using enteric coating polymers and finally compressed into MUPS tablet to avoid degradation of drug in acidic pH and irritation to gastric mucosa.
Experimental design and statistical modelling are essential tools for the development and understanding of complicated formulations and processes. Design of experiment (DoE) approach can be used to understand impact of formulation factors/process variables. Further it allows efficient experimentation covering a large number of factors which are varied together over a set of experiments, in contrast with the traditional approach of varying each factor while keeping other factors constant, which may fail to identify any interactions between these factors 9, 10, 11 . In current study, a computer-aided optimization technique using a three factor, two-level, full factorial design was used to investigate the effect of three process variables, i.e., Main compression force, Pre-compression force, and Turret speed.
MATERIALS & METHODS
Materials
Esomeprazole Magnesium was obtained as a gift sample from Hetero Drugs. Ludipress LCE and Crospovidone (Kollidon CL-F) was gifted from BASF. Prosolv SMCC HD 90, Prosolv SMCC 90 and Sodium stearyl fumarate were obtained from JRS Pharma. PEG 6000 was obtained from Sigma Aldrich. All the chemicals and reagents were of analytical reagent (AR) grade and used without further purifications.
Methods
Preparation of lubricated blend
All extra granular excipients were sifted through 30 mesh (Table 1) . Esomeprazole Magnesium over coated pellets with Prosolv SMCC HD 90 were co-sifted through 30 mesh, labelled as co-sift I. Crospovidone, PEG 6000 and 1/2th quantity of ludipress LCE were sifted through30 mesh and labelled as co-sift II. Aerosil with remaining quantity of ludipress LCE were sifted through 30 mesh, labelled as co-sift III. Initial pre-sifted Prosolv SMCC 90 added to double cone blender followed by co-sift I, co-sift II, co-sift III and mixed for 10 min with 10rpm. Table 2 summarizes these process variables with corresponding levels and the responses studied, whereas experimental runs with different process variables are listed in Table 3 . The variables were selected to measure the change in response from one extreme factor to another and for determining interactions, if any, among the factors with their best levels for optimizing the considered experimental responses. 
Dissolution studies
Dissolution studies were carried out in two stages. Dissolution in acidic condition i.e., 0.1N HCl for 2 hrs with volume 500 mL, USP apparatus II (Paddle)and temperature 37±0.5 o C followed by dissolution in pH 6.5,simulated intestinal condition for 45 min with volume 500 mL, USP apparatus II (Paddle) and temperature 37±0.5 o C.
Content uniformity -AV value
Content uniformity was evaluated by USP method (905) and acceptance value (AV) calculated at different turret speed and compression force.
Weight variation -% RSD
Weighed individually 20 tablets selected at random and calculated the average weight. Study repeated three times for each formulation (n=3). Weighing balance used Mettler Toledo.
Hardness
Tablet hardness was measured from the force required to fracture tablets by diametrical compression using a tablet hardness Tester (Erweka TBH200, Germany). Mean hardness of 10 tablets from each formulation was observed and reported as tablet hardness (n=10).
Friability
Friability of tablets was determined using Friabilator (Electrolab, India). Ten tablets were added in a friabilator at 25 rpm and dropping. The percent friability was then calculated by,
Where, Wo is the weight of the tablets before the test and W is the weight of the tablet after the test.
Statistical Analysis
Design Expert software was used for generation of polynomial models, including interaction terms for all response variables using multiple linear regression analysis. Polynomial models together with interaction terms were generated for all the response variables by means of multiple linear regression analysis. The influence of various process variables and their interaction with each of the responses are represented graphically. In order to validate the polynomial equations, one optimum checkpoint and three random checkpoints were selected by intensive grid search, performed over the entire experimental domain. Values were predicted for each process variable using a mathematical model developed for the optimized process and three additional random checkpoints covering the entire range of the experimental domain.
These predicted values were compared with the resulting experimental values and the percentage bias was calculated.
RESULTS AND DISCUSSION
Risk Assessment and Justification
A risk assessment of the Compression process was performed to identify the high-risk unit operations that could affect the final DP-CQAs. The process variables that could impact the identified drug product CQAs were the focus of risk assessment to determine which variables have the highest potential to cause CQA failures. These variables were then investigated in order to optimize compression process variables and mitigate the risk of failure.
The initial risk assessment of the compression process is shown in the 
Factorial design
Experiments were carried out to determine the mathematical relationship between the process variables acting on the system and the response of the system. The statistical evaluation of experimental outcomes was processed with Design Expert software to find the optimum levels.
A first order polynomial regression equation that fitted the data is as follows: Same can be observed from Pareto chart (Fig. 1a) , where main compression force and turret speed show effect more than Bonferroni limit showing almost certainly significant.
Weight Variation-(% RSD)
Hardness and Thickness
Main compression force and pre-compression force may have impact on Hardness of tablets which will have impact on drug product CQA. (Fig.1b and 1c) . For response thickness, main compression force showed negative effect i.e. increases in level of main compression force leads to decrease in thickness.
Content Uniformity -AV value
Unoptimized turret speed may have impact on content uniformity of final tablets, which will have impact on Assay of final tablets.
Content Uniformity -AV value= +4.65+ 2.02*C (F=302.33, P˂0.0001, R 2 =0.994)
From equation it is observed that turret speed has positive effect on content uniformity of tablets i.e. increase in turret speed leads to higher weight variation which finally impact on content uniformity of tablets.
Same can be observed from Pareto chart (Fig.1d) , where turret speed show effect more than Bonferroni limit showing almost certainly significant. (Fig.1e) , also shows that main compression force t-limit is above Bonferroni limits showing certainly significant whereas pre-compression force showed limits above tlimit showing possibly significant.
In case of response Drug release in pH 6.5 SIF at 15 min, only Main compression have significant impact (negative) same was observed in pareto chart (Fig.1f) .
Optimization using regression analysis and validation of mathematical model
With the help of above mentioned mathematical models, process variables were optimized keeping the constraints in range to have design space. The optimum calculated parameters were The experiments were carried out according to the process parameters obtained after applying constraints, and the optimum solution with process parameters was evaluated for its considered responses. Results obtained for responses are shown in table 6. In order to evaluate the reliability of the mathematical model developed, three additional checkpoints were taken, and estimated using a generated model covering the entire experimental domain. Table 6 gives the levels of variables of optimum formulation and three random checkpoints with their experimental values, predicted values, and the percent bias.
For the optimum solution process parameters ( 6 .5 SIF at 15min: 68% in the current study indicate the robustness of the mathematical model. From above studies, it is concluded that a quality Esomeprazole MUPS tablet was successfully evaluated designed using QbD approach for compression process variables.
